Skip to content
VuFind
English
Deutsch
Español
Français
Italiano
日本語
Nederlands
Português
Português (Brasil)
中文(简体)
中文(繁體)
Türkçe
עברית
Gaeilge
Cymraeg
Ελληνικά
Català
Euskara
Русский
Čeština
Suomi
Svenska
polski
Dansk
slovenščina
اللغة العربية
বাংলা
Galego
Tiếng Việt
Hrvatski
हिंदी
Հայերէն
Українська
Sámegiella
Монгол
Language
All Fields
Title
Author
Subject
Call Number
ISBN/ISSN
Tag
Find
Advanced
Results of a Large Randomized...
Cite this
Text this
Email this
Print
Export Record
Export to RefWorks
Export to EndNoteWeb
Export to EndNote
Permanent link
Results of a Large Randomized Controlled Trial of Alemtuzumab-Versus Basiliximab-Based Induction Therapy in Kidney Transplantation
Show other versions (1)
Bibliographic Details
Main Authors:
Haynes, R
,
Harden, P
,
Landray, M
,
Baigent, C
,
Friend, P
,
Grp, S
Format:
Conference item
Published:
2014
Holdings
Description
Other Versions (1)
Similar Items
Staff View
Similar Items
Results of a Large Randomized Controlled Trial of Alemtuzumab-Versus Basiliximab-Based Induction Therapy in Kidney Transplantation
by: Haynes, R, et al.
Published: (2014)
Alemtuzumab-based induction treatment versus basiliximab-based induction treatment in kidney transplantation (the 3C Study): a randomised trial.
by: Haynes, R, et al.
Published: (2014)
Effect of alemtuzumab or basiliximab induction therapy on graft function and survival of kidneys from donors after cardiac death.
by: Plata-Munoz, J, et al.
Published: (2009)
Induction Strategies in Lung Transplantation: Alemtuzumab vs. Basiliximab a Single-Center Experience
by: Masashi Furukawa, et al.
Published: (2022-06-01)
Elective conversion to sirolimus vs. continued tacrolimus in kidney transplantation (the 3c study): Results of a randomized trial
by: Haynes, R, et al.
Published: (2017)